PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Connolly, Stuart J.
TI  - Results from the RE-LY Trial
DP  - 2009 Dec 01
TA  - MD Conference Express
PG  - 17--20
VI  - 9
IP  - 4
4099  - http://mdc.sagepub.com/content/9/4/17.short
4100  - http://mdc.sagepub.com/content/9/4/17.full
AB  - Results from the Randomized Evaluation of Long-Term Anticoagulant Therapy [RE-LY] trial showed that the oral direct thrombin inhibitor dabigatran is a safe and effective alternative to warfarin for the prevention of stroke in patients with atrial fibrillation.